See more : Reflectkote, Inc. (RKTE) Income Statement Analysis – Financial Results
Complete financial analysis of The Trendlines Group Ltd. (TRNLY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Trendlines Group Ltd., a leading company in the Asset Management industry within the Financial Services sector.
- Suzhou Veichi Electric Co., Ltd. (688698.SS) Income Statement Analysis – Financial Results
- Grand City Properties S.A. (GYC.DE) Income Statement Analysis – Financial Results
- Pharol, SGPS S.A. (PHR.LS) Income Statement Analysis – Financial Results
- Dexco S.A. (DXCO3.SA) Income Statement Analysis – Financial Results
- PP Capital – Tactical Asset Allocation (PMICTAAKLNEUR.CO) Income Statement Analysis – Financial Results
The Trendlines Group Ltd. (TRNLY)
About The Trendlines Group Ltd.
The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments. The firm seeks to invest in food, clean technology, agritechnology, lifesciences with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies. It considers investments in Israel and Singapore. The firm offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and marketing communications services to entrepreneurs. The firm seeks to invest a minimum of $0.06 million in its portfolio companies. The firm prefers to exit its investments through merger and acquisition transactions, listing on public stock exchanges, or other dispositions of holdings. It leverages its own capital with government funding to mitigate risk in creating and developing new businesses. It is involved in all aspects of its portfolio companies from technology development to business building. The Trendlines Group Ltd. was founded in 1993 and is based in M.P. Misgav, Israel with additional offices in Tel Aviv, Israel; Beijing, China; and Singapore, Singapore.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | -20.99M | 3.58M | 2.30M | 3.72M | 5.50M | 6.24M | 5.21M | 7.21M | 4.56M | 5.95M | 29.52M | 13.77M |
Cost of Revenue | 5.65M | 8.10M | 8.51M | 2.11M | 938.45K | 4.80M | 5.67M | 5.32M | 4.83M | 5.75M | 5.53M | 4.63M |
Gross Profit | -26.64M | -4.52M | -6.21M | 1.61M | 4.56M | 1.44M | -463.00K | 1.89M | -264.00K | 205.00K | 23.99M | 9.14M |
Gross Profit Ratio | 126.91% | -126.44% | -269.71% | 43.34% | 82.94% | 23.06% | -8.89% | 26.26% | -5.79% | 3.44% | 81.27% | 66.36% |
Research & Development | 1.69M | 916.00K | 345.00K | 1.09M | 1.11M | 1.06M | 195.00K | 224.00K | 110.00K | 514.00K | 1.45M | 1.12M |
General & Administrative | 3.77M | 3.28M | 2.68M | 7.48M | 7.06M | 6.40M | 3.07M | 3.39M | 1.86M | 1.76M | 394.00K | 184.00K |
Selling & Marketing | 241.00K | 270.00K | 328.00K | 214.00K | 269.00K | 404.00K | 354.00K | 390.00K | 243.00K | 320.00K | 315.00K | 139.00K |
SG&A | 4.01M | 3.55M | 3.01M | 214.00K | 269.00K | 404.00K | 3.42M | 3.78M | 2.11M | 2.08M | 709.00K | 323.00K |
Other Expenses | 0.00 | 3.40M | -8.05M | 18.48M | 3.31M | 360.00K | 355.00K | 432.00K | 417.00K | 717.00K | 0.00 | 0.00 |
Operating Expenses | 1.93M | 7.86M | -4.70M | 19.78M | 4.69M | 13.90M | -5.03M | 12.65M | -2.20M | 2.84M | 680.00K | 410.00K |
Cost & Expenses | 11.75M | 15.96M | 3.81M | 19.78M | 4.69M | 13.90M | 645.00K | 17.97M | 2.63M | 8.59M | 6.21M | 5.04M |
Interest Income | 17.00K | 35.00K | 22.00K | 3.93M | 256.00K | 1.25M | 97.00K | 123.00K | 245.00K | 5.00K | 405.00K | 117.00K |
Interest Expense | 20.00K | 5.90M | 206.00K | 860.00K | 1.24M | 428.00K | 10.00K | 46.00K | 549.00K | 699.00K | 0.00 | 0.00 |
Depreciation & Amortization | 772.00K | 955.69K | 1.10M | 1.77M | 789.31K | 285.11K | 189.04K | 162.46K | 165.00K | 105.00K | 83.00K | 75.00K |
EBITDA | -33.93M | -17.83M | 2.68M | -11.56M | 2.16M | -5.77M | 5.77M | -9.69M | 2.52M | -1.81M | 23.37M | 9.38M |
EBITDA Ratio | 161.66% | -293.29% | 171.79% | -288.70% | 39.18% | -92.53% | 110.71% | -134.54% | 60.70% | -34.21% | 79.15% | 64.56% |
Operating Income | -32.74M | -11.42M | 2.85M | -12.09M | 1.38M | -5.86M | 5.59M | -9.86M | 2.35M | -1.92M | 23.29M | 8.81M |
Operating Income Ratio | 156.00% | -319.28% | 123.90% | -325.18% | 25.04% | -93.99% | 107.20% | -136.69% | 51.58% | -32.21% | 78.87% | 64.02% |
Total Other Income/Expenses | -2.58M | -6.20M | 3.19M | 227.00K | -671.00K | -65.18K | -356.39K | 796.00K | -3.49M | 127.00K | -376.00K | -204.00K |
Income Before Tax | -35.32M | -17.32M | 2.65M | -12.95M | 137.00K | -6.49M | 5.58M | -9.93M | -1.77M | -2.86M | 22.91M | 8.61M |
Income Before Tax Ratio | 168.30% | -484.04% | 114.95% | -348.32% | 2.49% | -104.01% | 107.01% | -137.78% | -38.89% | -47.97% | 77.60% | 62.54% |
Income Tax Expense | -600.79K | -2.16M | -3.36M | -9.00M | 832.00K | -168.00K | 1.64M | -3.36M | 1.79M | 1.36M | 6.19M | 2.64M |
Net Income | -34.00M | -15.16M | 6.56M | -3.95M | -695.00K | -6.12M | 3.86M | -6.58M | -3.30M | -2.81M | 15.96M | 5.83M |
Net Income Ratio | 161.97% | -423.78% | 285.22% | -106.30% | -12.64% | -98.16% | 74.15% | -91.23% | -72.31% | -47.28% | 54.04% | 42.32% |
EPS | -1.83 | -0.02 | 0.01 | -0.01 | 0.00 | -0.50 | 0.37 | -0.65 | -0.45 | -0.45 | 0.05 | 0.02 |
EPS Diluted | -1.83 | -0.02 | 0.01 | -0.01 | 0.00 | -0.50 | 0.37 | -0.65 | -0.45 | -0.45 | 0.05 | 0.02 |
Weighted Avg Shares Out | 18.56M | 840.46M | 791.19M | 791.19M | 655.20M | 12.17M | 10.51M | 10.17M | 7.31M | 6.32M | 319.72M | 300.45M |
Weighted Avg Shares Out (Dil) | 18.56M | 840.46M | 791.19M | 791.19M | 655.20M | 12.17M | 10.51M | 10.17M | 7.31M | 6.32M | 317.83M | 287.71M |
GE Aerospace Stock Could Bounce Off Bullish Trendlines
Limaca's Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment
Vensica Medical Secures $11M in Funding to Support Phase 2 Trials for Overactive Bladder Treatment
ElastiMed Welcomes Dr. Amir Belson as a Member of the Board of Directors
Natural Gas and Oil Forecast: Hurricane Disruptions Support Prices, Bearish Trendlines Loom
Arcuro Medical Exceeds 4,000 Case Milestone
Dasyo Welcomes Medical Aesthetics Industry Icon Domenic (Dom) Serafino as Executive Chair
Ceretrieve Announces Groundbreaking Success in FIH Ischemic Stroke Cases
ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
Arcuro Medical Appoints Jamal Rushdy CEO
Source: https://incomestatements.info
Category: Stock Reports